Reduction of SystemiC Inflammation After Ischemic Stroke by Intravenous DNase Administration (ReSCInD)
Reduction of SystemiC Inflammation After Ischemic Stroke by Intravenous DNase Administration (ReSCInD)
Recruiting · NCT05880524 · Registry updated 2026-09-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Reduction of SystemiC Inflammation After Ischemic Stroke by Intravenous DNase Administration (ReSCInD) | brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, ischemic stroke, nervous system disorder, stroke disorder, vascular disorder | Recruiting | Phase 2 | 2026-09-11 | NCT05880524 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Ludwig-Maximilians - University of Munich | 67 |
| University Hospital Erlangen | 16 |
| Universitätsklinikum Hamburg-Eppendorf | 136 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Charité Universitätsmedizin | Berlin | Germany | 5 |
| Institute for Stroke and Dementia Research, Ludwig Maximilian University Munich, University Hospital | Munich | Germany | 1 |
| MHH Hannover | Hanover | Germany | 1 |
| TUM Klinikum München | Munich | Germany | 1 |
| University Medical Center Hamburg-Eppendorf | Hamburg | Germany | 24 |